Brief: Aquestive Therapeutics Reports First Quarter 2023 Financial Results And Provides Business Update

Aquestive Therapeutics

02/05/2023 23:22

May 2 (Reuters) - Aquestive Therapeutics Inc:
    * AQUESTIVE THERAPEUTICS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * SEES FOR THE REMAINDER OF 2023 TOTAL REVENUE $42 MILLION
TO $46
MILLION
    * SEES FOR REMAINDER OF 2023 NON-GAAP ADJUSTED EBITDA LOSS 
$24
MILLION TO $28 MILLION
    * FY2023 REVENUE VIEW $39.1 MILLION -- REFINITIV IBES DATA
    * CASH AND CASH EQUIVALENTS WERE $26.9 MILLION AS OF MARCH
31,
2023
    * TOTAL REPORTED REVENUES WERE $11.1 MILLION IN Q1 2023,
COMPARED
TO $12.3 MILLION IN Q1 2022
    * NET INCOME FOR Q1 2023 WAS $8.1 MILLION, OR $0.15 BASIC
EARNINGS
PER SHARE AND $0.11 DILUTED EARNINGS PER SHARE
    * Q1 EARNINGS PER SHARE VIEW $-0.19, REVENUE VIEW $9.9
MILLION --
REFINITIV IBES DATA

Further company coverage:  AQST.O 

 ((Reuters.Briefs@thomsonreuters.com;))